MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The role of acoustic salience in acoustic cueing and sound-based motor rehabilitation

    B.G. Schultz, S.A. Kotz (Maastricht, Netherlands)

    Objective: To evaluate the underlying mechanisms for motor rehabilitation in acoustic cueing and sound therapies with a specific focus on patterns of auditory salience. Background:…
  • 2016 International Congress

    Physiotherapy can reduce the decline in functioning according to ICF framework in patients in early stage of Parkinson’s disease evolution

    E.T.N. Guelfi, E. Okamoto, F.B. Tarallo, J.C. Elmauer, R.R. Fermino, V.F. Giangiardi, P. Yuki, E.P. Piemonte (São Paulo, Brazil)

    Objective: To investigate the effects of physiotherapy treatment on functioning according to International Classification of Functioning, Disability and Health (ICF) framework in patients in early…
  • 2016 International Congress

    Safety of nelotanserin in a randomized placebo-controlled phase 2 study

    W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, S. Piscitelli, M. Sanchez, W. Shanahan (New York, NY, USA)

    Objective: To explore the safety of nelotanserin in a phase 2 study in patients with nelotanserin. Background: Nelotanserin is a highly selective and poent inverse…
  • 2016 International Congress

    Effect of nelotanserin on objective sleep parameters in a phase 2 study in patients with insomnia

    W. Wen, L. Friedhoff, K. Kishnani, S. Ramaswamy, M. Sanchez, W. Shanahan (New York, NY, USA)

    Objective: To understand the effects of nelotanserin on objective sleep parameters in a phase 2 study in patients with primary insomnia. Background: Nelotanserin is a…
  • 2016 International Congress

    Adult onset Niemann-Pick type C: 24 month follow-up on miglustat

    B. Elibol, F. Ozkinay, H. Onder (Ankara, Turkey)

    Objective: To present a rare case of adult onset NPC patient and pointing out varying response of her distinct symptoms on long term follow up…
  • 2016 International Congress

    STRONG VOICE: Design of a multisite, open-label, longitudinal registry for patients with neurogenic dysphonia/dysphagia treated with vocal fold augmentation

    K.D. Sethi, A. Verma, C.A. Rosen, C.H. Adler, C.J. Bassich, T.L. Carroll, M.D. Stacy (Raleigh, NC, USA)

    Objective: To describe the benefits and risks of vocal fold augmentation treatment for patients with neurogenic dysphonia/dysphagia. Background: Neurogenic dysphonia/dysphagia represents laryngeal dysfunction, usually with…
  • 2016 International Congress

    Glial cells and iron accumulation in the brain of the Zitter rat

    T. Kadowaki, H. Lassmann, S. Ueda, C. Schuh, K. Hirata (Mibu, Japan)

    Objective: To investigate relationship between glial cell and iron accumulation in the brain of the Zitter rat, which is one of neurodegenerative disease model. Background:…
  • 2016 International Congress

    Improving the experience of diagnosis in Parkinson’s disease

    C. Carroll, B. Blight, V. Evans, N. Hawkes, J. Davis (Plymouth, United Kingdom)

    Objective: To identify areas in which patient experience of being diagnosed with Parkinson's can be improved. Background: Receiving a Parkinson's diagnosis can leave patients feeling…
  • 2016 International Congress

    Beyond 30 years of Parkinson’s disease: A comprehensive characterization of long-surviving patients

    A. Romagnolo, M.G. Rizzone, F. Dematteis, M. Zibetti, A. Merola, L. Rizzi, E. Montanaro, C.A. Artusi, M. Lanotte, L. Lopiano (Turin, Italy)

    Objective: To analyze the features of very late stage Parkinson's disease (PD) in a selected group of patients treated with bilateral subthalamic nucleus DBS (STN-DBS),…
  • 2016 International Congress

    Biochemical features of lipids spectrum in blood in patients with Parkinson’s disease

    Z.A. Akbarkhodjaeva, F. Saidvaliev (Tashkent, Uzbekistan)

    Objective: To study characteristic of lipid levels in patients with PD. Background: Currently, there is no clear data about the features of lipid metabolism in…
  • « Previous Page
  • 1
  • …
  • 1702
  • 1703
  • 1704
  • 1705
  • 1706
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley